You are here: Home » Current Affairs » Coronavirus » News
US reports 1 million new coronavirus cases in a month, death toll soaring
Does Trump's defeat in US elections signal the start of populism's decline?
Business Standard

EU to buy up to 300 million doses of Pfizer-BioNTech Covid-19 vaccine

The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer

Pfizer | Coronavirus Vaccine | Coronavirus Tests

AP  |  Brussels 

Coronavirus, vaccine, covid, drugs, clinical trials
Representative photo of a vaccine

The European Commission will sign a deal to secure up to 300 million doses of the experimental vaccine developed by BioNTech and .

Ursula von der Leyen, the president of the EU's executive arm, said the commission will authorize the deal on Wednesday after working tirelessly to secure doses of potential vaccines in recent months.

This is the most promising vaccine so far, von der Leyen said. Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe. said Monday that early results from the vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19.

The European Commission had already secured three other deals with pharmaceutical companies allowing its 27 member states to buy nearly one billion doses of a potential vaccine.

And more will come. Because we need to have a broad portfolio of vaccines based on different technologies, von der Leyen said. We have already started working with member states to prepare national vaccination campaigns. We are almost there. In the meantime, let us be prudent, and stay safe.

The commission said once a vaccine is ready, member states should have access to it at the same time, and give priority to groups including healthcare workers and people over 60 years, as well as people with health conditions making them more vulnerable.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, November 11 2020. 09:21 IST